Catalyst Wire Dossier Catalyst Wire Dossier

Purified Poloxamer 188

poloxamer 188 · Mast Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Purified Poloxamer 188, covering 2016-10-28 to 2016-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) [Phase 3]

See pricing